OxThera Intellectual Property AB
556744-2677InactiveDeveloping novel biotherapies for rare kidney diseases like Primary Hyperoxaluria.
Oversikt
- 0
- Ansatte
- ≤1t SEK
- Omsetning
- 2007
- Grunnlagt
Beskrivelse
OxThera AB is a privately-held biopharmaceutical company dedicated to developing novel treatment options for rare kidney diseases, primarily Primary Hyperoxaluria (PH). Their core mission is to improve the quality of life and extend the life expectancy of patients suffering from this devastating ult...
Tagger
Nøkkelord
Bedriftsinformasjon
- Bransje
- Övrig verksamhet inom juridik, ekonomi, vetenskap och teknik
- Juridisk form
- Aktiebolag
- MVA-nummer
- SE556744267701
Beslutningstakere
Ingen beslutningstakere funnet ennå
Lignende bedrifter
20 lignende bedrifter i FunnelfeedrBioGaia Pharma AB
0 ansatteDeveloping and out-licensing novel biotherapeutic platforms from microbiome research.
ULTRAGENYX EUROPE GMBH
1–4 ansatteAdvancing transformative medicines for rare and ultra-rare genetic diseases globally.
Calliditas Therapeutics AB
20–49 ansattePioneering novel treatments for rare renal and hepatic diseases globally.
Sixera Pharma AB
1–4 ansatteSmall biotech developing first treatment for rare Netherton syndrome.
AUTHERA AS
5 ansatteDeveloping novel FcRn-targeting biologics for therapeutic applications.
Utforsk mer
Spørsmål om OxThera Intellectual Property AB
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo